11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
Chi-lai Ho, Sirong Chen, Yim Lung Leung, Thomas Cheng, Ka-nin Wong, Shing Kee Cheung, Raymond Liang, Chor Sang Chim
Index: J. Nucl. Med. 55(5) , 749-52, (2014)
Full Text: HTML
Abstract
We prospectively compared (11)C-acetate with (18)F-FDG in a PET/CT evaluation of multiple myeloma (MM), specifically on diagnostic accuracy, identification of high-risk patients, and monitoring of treatment response.Dual-tracer PET/CT was performed on 35 pathologically and clinically confirmed and untreated patients (26 with symptomatic MM, 5 with smoldering MM, and 4 with monoclonal gammopathy of unknown significance) and 20 individuals with normal marrow.(11)C-acetate showed significant incremental value over (18)F-FDG (84.6% vs. 57.7%) for positively identifying patients with diffuse and focal symptomatic MM, and was negative in patients with indolent smoldering MM and monoclonal gammopathy of unknown significance. Three functional parameters-number of (11)C-acetate-avid and (18)F-FDG-avid focal bone lesions and (11)C-acetate general marrow activity-strongly correlated with β-2-microglobulin as surrogate imaging markers of tumor burden. After induction chemotherapy, the metabolic change in (11)C-acetate general marrow activity correlated with clinical response.Metabolic characterization of MM in diagnosis, risk stratification, and treatment monitoring can be done more accurately by assessing lipid metabolism with (11)C-acetate than by assessing glucose metabolism with (18)F-FDG.
Related Compounds
Related Articles:
2014-01-01
[Protein Pept. Lett. 21(11) , 1163-75, (2014)]
2014-08-01
[Anal. Bioanal. Chem 406(20) , 4851-9, (2014)]
2014-08-15
[J. Bacteriol. 196(16) , 3045-57, (2014)]
Direct silylation of Trypanosoma brucei metabolites in aqueous samples and their GC-MS/MS analysis.
2014-09-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 967 , 134-8, (2014)]
2016-01-01
[Bioresour. Technol. 200 , 624-30, (2015)]